LAZCLUZE 240 MG COMPRIMIDOS RECUBIERTOS CON PELICULA
LAZCLUZE 240 MG COMPRIMIDOS RECUBIERTOS CON PELICULA
Pending
Register Number
1241886005
Prescription Type
Diagnóstico Hospitalario
Authorization Date
Jan 29, 2025
Dosage Form
COMPRIMIDO RECUBIERTO CON PELÍCULA
Route: VÍA ORAL
Product Details
Detailed information about this CIMA AEMPS approved pharmaceutical product.
Basic Information
Key regulatory and product classification details
Regulatory Details
Register Number1241886005
EMA Approved
Yes
Drug Classification
✗
Generic
No
✗
Orphan
No
✗
Biosimilar
No
✗
Commercialized
No
CIMA AEMPS Classification
INGREDIENTS (1)
LAZERTINIBActive
Quantity: 240 mg
Name: LAZERTINIB
ATC CLASSIFICATION (3)
L01E
L01EB
L01EB09